TY  - JOUR
A1  - Nast, Alexander
A1  - Kopp, Ina
A1  - Augustin, Matthias
A1  - Banditt, Kirstin-Benita
A1  - Boehncke, Wolf-Henning
A1  - Follmann, Markus
A1  - Friedrich, Markus
A1  - Huber, Matthias
A1  - Kahl, Christina
A1  - Klaus, Joachim
A1  - Koza, Joachim
A1  - Kreiselmaier, Inga
A1  - Mohr, Johannes
A1  - Mrowietz, Ulrich
A1  - Ockenfels, Hans-Michael
A1  - Orzechowski, Hans-Dieter
A1  - Prinz, Jörg
A1  - Reich, Kristian
A1  - Rosenbach, Thomas
A1  - Rosumeck, Stefanie
A1  - Schlaeger, Martin
A1  - Schmid-Ott, Gerhard
A1  - Sebastian, Michael
A1  - Streit, Volker
A1  - Weberschock, Tobias Bernd
A1  - Rzany, Berthold
T1  - German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version)
T2  - Archives of Dermatological Research
N2  - Psoriasis vulgaris is a common and chronic inflammatory skin disease which has the potential to significantly reduce the quality of life in severely affected patients. The incidence of psoriasis in Western industrialized countries ranges from 1.5 to 2%. Despite the large variety of treatment options available, patient surveys have revealed insufficient satisfaction with the efficacy of available treatments and a high rate of medication non-compliance. To optimize the treatment of psoriasis in Germany, the Deutsche Dermatologische Gesellschaft and the Berufsverband Deutscher Dermatologen (BVDD) have initiated a project to develop evidence-based guidelines for the management of psoriasis. The guidelines focus on induction therapy in cases of mild, moderate, and severe plaque-type psoriasis in adults. The short version of the guidelines reported here consist of a series of therapeutic recommendations that are based on a systematic literature search and subsequent discussion with experts in the field; they have been approved by a team of dermatology experts. In addition to the therapeutic recommendations provided in this short version, the full version of the guidelines includes information on contraindications, adverse events, drug interactions, practicality, and costs as well as detailed information on how best to apply the treatments described (for full version, please see Nast et al., JDDG, Suppl 2:S1–S126, 2006; or http://www.psoriasis-leitlinie.de).
KW  - Evidence-based guidelines
KW  - Psoriasis vulgaris
KW  - Treatment
Y1  - 2007
UR  - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/529
UR  - https://nbn-resolving.org/urn:nbn:de:hebis:30-50480
SN  - 1432-069X
SN  - 0340-3696
N1  - © Springer-Verlag 2007. An enhanced version of these guidelines has been published with Blackwell in 2006.
VL  - 299
IS  - 3
SP  - 111
EP  - 138
PB  - Springer
CY  - Berlin ; Heidelberg ; New York
ER  -